Form 4: Hinge Health CFO James Budge Receives RSU Grant

Hinge Health CFO James Budge was granted 65,000 restricted stock units as part of an exempt equity award.

Summary

• James Budge, Chief Financial Officer of Hinge Health, Inc., acquired 65,000 restricted stock units (RSUs).
• The transaction occurred on April 29, 2026.
• Each RSU represents a right to receive one share of Class A Common Stock upon vesting for no consideration.
• Following this transaction, the reporting person's total beneficial ownership is 451,293 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation with no material impact on company operations or financial health.

Positives

• Equity-based compensation aligns the interests of the CFO with long-term shareholder value.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The filing does not provide forward-looking financial guidance.

Industry Context

StockSavvy.ai notes that executive equity grants are standard corporate governance practices intended to incentivize leadership performance and retention.

Comparison to Industry Standards

• The issuance of RSUs as part of executive compensation is consistent with standard practices for publicly traded technology and healthcare companies.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of the granted RSUs according to the company's equity incentive plan.

Key Dates

Keywords

Hinge Health, HNGE, CFO, Insider Trading, Form 4, Equity Compensation